Ginkgo Bioworks Holdings (DNA)

Ginkgo Bioworks Holdings (DNA) is a Biotechnology company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $692M; returns 1 day +2.9%, 1 week -2.7%, 1 year -24.4%.

Ginkgo Bioworks Holdings, Inc. (DNA) is a leading synthetic biology company that operates a horizontal platform for cell programming, aiming to make biology easier to engineer across various industries. Its business model is primarily driven by two revenue streams: Foundry (Cell Engineering) and Biosecurity.

Groups DNA belongs to

• Biotechnology
• Life Sciences
• Artificial Intelligence
• R&D
• Life Sciences Tools & Services
• Healthcare Technology
• Automation
• Drug Discovery
• Public Safety and Security

DNA financial model: income statement, cash flow and balance sheet